Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
Crossref DOI link: https://doi.org/10.1007/s00417-017-3624-y
Published Online: 2017-02-25
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bahrami, Bobak
Hong, Thomas
Zhu, Meidong
Schlub, Timothy E.
Chang, Andrew
Funding for this research was provided by:
Bayer Corporation
License valid from 2017-02-25